Systemic Exposure to Rifampicin in Patients With Tuberculosis and Advanced HIV Disease During Highly Active Antiretroviral Therapy in Burkina Faso

Journal of Antimicrobial Chemotherapy - United Kingdom
doi 10.1093/jac/dkr445
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Oxford University Press (OUP)

Related search

Recurrent Pulmonary Sarcoidosis in HIV-Infected Patients Receiving Highly Active Antiretroviral Therapy

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2001English

Highly Active Antiretroviral Therapy and Changing Spectrum of Liver Diseases in HIV Infected Patients

International Journal of Research in Medical Sciences
2016English

Adherence to Highly Active Antiretroviral Therapy and Its Correlates Among HIV Infected Pediatric Patients in Ethiopia

BMC Pediatrics
Child HealthPediatricsPerinatology
2008English

Highly Active Antiretroviral Therapy Compared With HAART and Bosentan in Combination in Patients With HIV-associated Pulmonary Hypertension

Heart
Cardiovascular MedicineCardiology
2006English

Effect of Tuberculosis Co Infection on Virological Failure in HIV Patients on First Line of Highly Active Antiretroviral Therapy

International Journal of Current Microbiology and Applied Sciences
2017English

Risk Factors for Blastocystis Infection in HIV/AIDS Patients With Highly Active Antiretroviral Therapy in Southwest China

Infectious Diseases of Poverty
MedicineEnvironmentalPublic HealthInfectious DiseasesOccupational Health
2019English

Immune Reconstitution in HIV-1 Infected Patients Treated for Two Years With Highly Active Antiretroviral Therapy

Journal of Venomous Animals and Toxins Including Tropical Diseases
Animal ScienceZoologyParasitologyInfectious DiseasesToxicology
2006English

HIV Neutralizing Antibody Titer During Structured Treatment Interruption of Highly Active Antiretroviral Therapy

AIDS
Infectious DiseasesAllergyImmunology
2012English

Patients' Readiness to Start Highly Active Antiretroviral Treatment for HIV

BMJ
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy